Experimental Drug Shows Promise for Disfiguring Tumor Condition
17 of 24 children with neurofibromatosis type 1 saw improvement, but more study neededContinue Reading
17 of 24 children with neurofibromatosis type 1 saw improvement, but more study neededContinue Reading
Local sun-safety campaigns may be key to progress against the deadly skin cancer, researchers sayContinue Reading
Cimaglermin appears to strengthen cells and improve heart function, researchers reportContinue Reading
Emotion-provoking events prime the brain to remember things more effectively, researchers findContinue Reading
Drug manufacturer says it will seek regulatory approval by end of 2017Continue Reading
Treatment nearly doubled survival or more, study findsContinue Reading
Specialist hopes ocrelizumab will be available by springContinue Reading
Brain scans revealed that those with the reading disorder showed less ability to ‘adapt’ to sensory informationContinue Reading
Removing healthy breast is unlikely to extend survival, but some doctors don’t mention this, researchers sayContinue Reading
Dexcom G5 is first continuous glucose monitoring system that can be used for treatment decisionsContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.